David P. Kay

869 total citations
12 papers, 608 citations indexed

About

David P. Kay is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David P. Kay has authored 12 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in David P. Kay's work include Quinazolinone synthesis and applications (3 papers), Chemical Synthesis and Analysis (2 papers) and DNA Repair Mechanisms (2 papers). David P. Kay is often cited by papers focused on Quinazolinone synthesis and applications (3 papers), Chemical Synthesis and Analysis (2 papers) and DNA Repair Mechanisms (2 papers). David P. Kay collaborates with scholars based in United States. David P. Kay's co-authors include Steven J. Durrant, Saroop S. Matharu, Jean‐Damien Charrier, Julian M.C. Golec, Ronald M. A. Knegtel, P. D. KENNEWELL, Mike O’Donnell, Somhairle MacCormick, Joanne L. Pinder and John R. Pollard and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of the Chemical Society Perkin Transactions 1.

In The Last Decade

David P. Kay

12 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David P. Kay United States	9	356	226	169	35	33	12	608
Peter Chua Canada	11	443 1.2×	323 1.4×	111 0.7×	28 0.8×	28 0.8×	14	766
Marc Lang Switzerland	12	307 0.9×	225 1.0×	156 0.9×	15 0.4×	39 1.2×	26	544
Robert B. Warner United States	10	413 1.2×	502 2.2×	160 0.9×	35 1.0×	19 0.6×	19	873
Michael R. Michaelides United States	16	261 0.7×	338 1.5×	155 0.9×	32 0.9×	44 1.3×	24	633
J. Adam Willardsen United States	13	270 0.8×	479 2.1×	78 0.5×	44 1.3×	31 0.9×	22	712
Kevin Blades United Kingdom	17	576 1.6×	555 2.5×	217 1.3×	42 1.2×	42 1.3×	28	1.0k
Bernard Barlaam United Kingdom	17	448 1.3×	306 1.4×	256 1.5×	27 0.8×	51 1.5×	40	811
Shaun Fillery United Kingdom	11	334 0.9×	236 1.0×	121 0.7×	21 0.6×	40 1.2×	17	569
Mauro Angiolini Italy	10	387 1.1×	247 1.1×	139 0.8×	42 1.2×	94 2.8×	14	587
Susan E. Kephart United States	9	317 0.9×	193 0.9×	142 0.8×	49 1.4×	27 0.8×	14	571

Countries citing papers authored by David P. Kay

Since Specialization

Citations

This map shows the geographic impact of David P. Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Kay more than expected).

Fields of papers citing papers by David P. Kay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Kay. The network helps show where David P. Kay may publish in the future.

Co-authorship network of co-authors of David P. Kay

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Kay. A scholar is included among the top collaborators of David P. Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Kay. David P. Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Knegtel, Ronald M. A., Jean‐Damien Charrier, Steven J. Durrant, et al.. (2019). Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase Inhibitor. Journal of Medicinal Chemistry. 62(11). 5547–5561. 41 indexed citations

Charrier, Jean‐Damien, Andrew T. Miller, David P. Kay, et al.. (2011). Discovery and Structure−Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors. Journal of Medicinal Chemistry. 54(7). 2341–2350. 46 indexed citations

Charrier, Jean‐Damien, Steven J. Durrant, Julian M.C. Golec, et al.. (2011). Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents. Journal of Medicinal Chemistry. 54(7). 2320–2330. 192 indexed citations

Pinder, Joanne L., Steven J. Durrant, Jean‐Damien Charrier, et al.. (2006). Synthesis of a Stable Pyridyl Boronate and Its Reaction with Aryl and Heteroaryl Halides. Heterocycles. 70(1). 509–509. 3 indexed citations

Pierce, Albert C., et al.. (2005). CH···O and CH···N Hydrogen Bonds in Ligand Design: A Novel Quinazolin-4-ylthiazol-2-ylamine Protein Kinase Inhibitor. Journal of Medicinal Chemistry. 48(4). 1278–1281. 67 indexed citations

Golec, Julian M.C., Michael D. Mullican, Mark A. Murcko, et al.. (1997). Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme. Bioorganic & Medicinal Chemistry Letters. 7(17). 2181–2186. 20 indexed citations

Kuo, Elizabeth, P. Hambleton, David P. Kay, et al.. (1996). Synthesis, Structure−Activity Relationships, and Pharmacokinetic Properties of Dihydroorotate Dehydrogenase Inhibitors: 2-Cyano-3-cyclopropyl-3-hydroxy- N-[3‘-methyl-4‘-(trifluoromethyl)phenyl]propenamide and Related Compounds. Journal of Medicinal Chemistry. 39(23). 4608–4621. 76 indexed citations

Mullican, Michael D., Roger J. Gillespie, Saroop S. Matharu, et al.. (1994). The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.. Bioorganic & Medicinal Chemistry Letters. 4(19). 2359–2364. 21 indexed citations

Kay, David P., et al.. (1988). Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles. Journal of Medicinal Chemistry. 31(6). 1098–1115. 120 indexed citations

10.

Kay, David P., P. D. KENNEWELL, & Robert Westwood. (1982). The synthesis and reactions of 4H-tetrazolo[5,1-c][1,4]benzothiazines. Journal of the Chemical Society Perkin Transactions 1. 1879–1879. 3 indexed citations

11.

Kay, David P., et al.. (1979). Thermal decomposition of a sulfoximide in the presence of a carboxylic acid; an interesting rearrangement. Journal of Heterocyclic Chemistry. 16(6). 1089–1091. 1 indexed citations

12.

Kay, David P., et al.. (1977). Central nervous system activity of a novel class of annelated 1,4-benzodiazepines, aminomethylene-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-ones. Journal of Medicinal Chemistry. 20(8). 1035–1041. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact